Vedolizumab for inflammatory bowel diseasesI
Aim of review. To present literature data on administration of vedolizumab at inflammatory bowel diseases. Summary. The vedolizumab is anti-α4β7-integrin humanized class IgG1 antibodies which suppresses migration of leukocytes in intestinal tissue, interfering thereby with development of pathol...
| Published in: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2018-08-01
|
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/99 |